Triple
T20971653
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Epsilon Microscopii |
E516512
|
entity |
| Predicate | catalogIdentifier |
P8090
|
FINISHED |
| Object | CD−47 13677 |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CD−47 13677 | Statement: [Epsilon Microscopii, catalogIdentifier, CD−47 13677]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: CD−47 13677 Context triple: [Epsilon Microscopii, catalogIdentifier, CD−47 13677]
-
A.
CD−37 11636
CD−37 11636 is a catalog designation for Lesath, a bright B-type star in the constellation Scorpius that forms part of the Scorpion’s stinger.
-
B.
CD−45 13193
CD−45 13193 is a catalog designation for Epsilon Telescopii, a bright giant star in the southern constellation Telescopium.
-
C.
Nectin-4/CD137 (via BT7480)
Nectin-4/CD137 (via BT7480) refers to the tumor-targeted immune agonist mechanism of BT7480, a Bicycle Therapeutics drug candidate designed to engage Nectin-4–expressing cancer cells while activating the CD137 costimulatory receptor to stimulate anti-tumor immune responses.
-
D.
CD274
CD274, also known as PD-L1, is an immune checkpoint protein expressed on various cells that helps tumors evade immune detection and is a key target of several cancer immunotherapies.
-
E.
CD−24 13810
CD−24 13810 is a hot, massive O-type star in the constellation Sagittarius, better known as 9 Sagittarii.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: CD−47 13677 Target entity description: CD−47 13677 is a catalog designation for the star Epsilon Microscopii, a stellar object located in the constellation Microscopium.
-
A.
CD−37 11636
CD−37 11636 is a catalog designation for Lesath, a bright B-type star in the constellation Scorpius that forms part of the Scorpion’s stinger.
-
B.
CD−45 13193
CD−45 13193 is a catalog designation for Epsilon Telescopii, a bright giant star in the southern constellation Telescopium.
-
C.
Nectin-4/CD137 (via BT7480)
Nectin-4/CD137 (via BT7480) refers to the tumor-targeted immune agonist mechanism of BT7480, a Bicycle Therapeutics drug candidate designed to engage Nectin-4–expressing cancer cells while activating the CD137 costimulatory receptor to stimulate anti-tumor immune responses.
-
D.
CD274
CD274, also known as PD-L1, is an immune checkpoint protein expressed on various cells that helps tumors evade immune detection and is a key target of several cancer immunotherapies.
-
E.
CD−24 13810
CD−24 13810 is a hot, massive O-type star in the constellation Sagittarius, better known as 9 Sagittarii.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e0b4fee5ac8190875fa9ceba1a5e5e |
completed | April 16, 2026, 10:07 a.m. |
| NER | Named-entity recognition | batch_69e6fba027708190a49e95b0031d980d |
completed | April 21, 2026, 4:22 a.m. |
Created at: April 16, 2026, 1:44 p.m.